Using nanoparticles to reduce oxidative stress in traumatic brain injury
Nanoparticle-mediated reduction of oxidative stress for the treatment of traumatic brain injury
This study is looking at a new way to help people recover from traumatic brain injuries by using tiny particles to reduce damage in the brain, aiming to improve healing and lessen long-term problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Lincoln NIH-funded |
| Lab location | 1 site (Lincoln, United States) |
| Project ID | NIH-10676967 on NIH RePORTER |
What this research studies
This research focuses on developing a treatment for traumatic brain injury (TBI) by using nanoparticles to reduce oxidative stress, which is a significant contributor to brain damage following injury. The approach aims to improve the delivery and retention of therapeutic agents in the brain, targeting the secondary injuries that occur after the initial trauma. By addressing the mechanisms that lead to neurodegeneration and neuroinflammation, the research seeks to enhance recovery and minimize long-term impairments in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have recently experienced a traumatic brain injury.
Not a fit: Patients with chronic neurological conditions unrelated to traumatic brain injury may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for patients suffering from traumatic brain injury, potentially reducing long-term cognitive and physical impairments.
How similar studies have performed: While there have been various approaches to treating oxidative stress in brain injuries, this specific nanoparticle-mediated method is relatively novel and has not been extensively tested in large-scale trials.
Where this research is happening
Lincoln, United States
- University of Nebraska Lincoln — Lincoln, United States (Active)
Researchers
- Principal investigator: Kievit, Forrest M — University of Nebraska Lincoln
- Study coordinator: Kievit, Forrest M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.